Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Hruby

Showing results (501-510 of 504) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 504 results.
Molecular Pharmacology|December 1, 1996
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonistsE V Varga, X Li, D Stropova, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 18, 2013
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effectsT M Largent-Milnes, S W Brookshire, D P Skinner, et al.
European Journal of Pharmacology|February 17, 2000
delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout miceY Hosohata, T W Vanderah, T H Burkey, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptideG Li, W Haq, L Xiang, et al.
Pageof 51

Showing results (501-510 of 504) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 504 results.
Molecular Pharmacology|December 1, 1996
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonistsE V Varga, X Li, D Stropova, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 18, 2013
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effectsT M Largent-Milnes, S W Brookshire, D P Skinner, et al.
European Journal of Pharmacology|February 17, 2000
delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout miceY Hosohata, T W Vanderah, T H Burkey, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptideG Li, W Haq, L Xiang, et al.
Pageof 51